Guardian Wealth Advisors, LLC Eli Lilly & CO Transaction History

Guardian Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$310.63 - $364.82 $95,363 - $111,999	307 New	307 $105,000
Q3 2022 Nov 09, 2022	BUY	$296.48 - $337.87 $322,273 - $367,264	1,087 New	1,087 $351,000
Q2 2021 Jul 28, 2021	SELL	$180.55 - $233.54 $407,681 - $527,333	-2,258 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$164.32 - $212.72 $371,034 - $480,321	2,258 New	2,258 $421,000

4,016

739M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Guardian Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Guardian Wealth Advisors, LLC with notifications on news.